|
|
|
Insider
Information: |
Thompson Tommy G |
Relationship: |
Director |
City: |
Saint Louis |
State: |
MO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
2,385,169 |
|
Indirect Shares
|
5,118,253 |
|
|
Direct
Value |
$22,878,501 |
|
|
Indirect Value
|
$15,497,204 |
|
|
Total
Shares |
7,503,422 |
|
|
Total
Value |
$38,375,705 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
3
|
Stock
price went up :
|
1
|
3
|
Stock
price went down : |
4
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
-26.9%
|
104.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Centene Corp |
CNC |
Director |
2021-12-31 |
227,334 |
2021-12-31 |
160,896 |
Premium* |
|
CR Bard Inc |
BCR |
Director |
2017-12-29 |
0 |
2005-10-03 |
0 |
Premium* |
|
Pure Bioscience |
PURE |
Director |
2009-07-01 |
589,537 |
2007-05-23 |
0 |
Premium* |
|
United Therapeutics Corp |
UTHR |
|
2024-03-11 |
8,480 |
2024-03-08 |
14,000 |
Premium* |
|
Careview Communications Inc |
CRVW |
Director |
2012-12-26 |
1,325,222 |
2013-04-01 |
4,845,424 |
Premium* |
|
Plus Therapeutics Inc |
PSTV |
Director |
2015-05-08 |
103,986 |
2015-09-03 |
83,600 |
Premium* |
|
Therapeuticsmd Inc |
TXMD |
Director |
2022-08-18 |
5,954 |
2022-08-18 |
14,333 |
Premium* |
|
Physicians Realty Trust |
DOC |
Director |
2024-03-01 |
0 |
2024-03-01 |
0 |
Premium* |
|
Vyant Bio Ord Shs |
VYNT |
Director |
2013-10-10 |
2,500 |
2013-10-10 |
0 |
Premium* |
|
Healthpeak Properties |
PEAK |
Director |
2024-04-26 |
122,156 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
284 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PURE |
Pure Bioscience |
Director |
|
2008-07-24 |
4 |
S |
$5.20 |
$52,000 |
D/D |
(10,000) |
358,000 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2012-06-08 |
4 |
OE |
$26.75 |
$53,500 |
D/D |
2,000 |
70,777 |
0 |
- |
|
BCR |
CR Bard Inc |
Director |
|
2017-05-23 |
4 |
OE |
$83.47 |
$58,431 |
D/D |
700 |
7,704 |
0 |
- |
|
BCR |
CR Bard Inc |
Director |
|
2017-05-23 |
4 |
D |
$308.00 |
$58,519 |
D/D |
(190) |
7,514 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2016-09-26 |
4 |
OE |
$48.11 |
$62,110 |
D/D |
1,291 |
1,291 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2009-01-08 |
4 |
S |
$3.29 |
$65,700 |
D/D |
(20,000) |
602,800 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2009-01-09 |
4 |
S |
$3.32 |
$66,476 |
D/D |
(20,000) |
572,837 |
0 |
- |
|
TXMD |
Therapeuticsmd Inc |
Director |
|
2015-08-20 |
4 |
B |
$6.29 |
$67,962 |
I/I |
10,798 |
10,000 |
2.1 |
- |
|
DOC |
Physicians Realty Trust |
Director |
|
2019-03-04 |
4 |
A |
$18.09 |
$68,525 |
D/D |
3,788 |
103,581 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
|
|
2022-03-03 |
4 |
OE |
$48.11 |
$72,165 |
D/D |
1,500 |
8,020 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
|
|
2022-03-15 |
4 |
OE |
$48.11 |
$72,165 |
D/D |
1,500 |
8,020 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
|
|
2022-03-16 |
4 |
OE |
$48.11 |
$72,165 |
D/D |
1,500 |
8,020 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
|
|
2022-03-29 |
4 |
OE |
$48.11 |
$72,165 |
D/D |
1,500 |
8,020 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
|
|
2022-03-17 |
4 |
OE |
$48.11 |
$72,598 |
D/D |
1,509 |
8,029 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2005-04-26 |
4 |
A |
$29.05 |
$74,978 |
D/D |
2,581 |
2,581 |
|
- |
|
CNC |
Centene Corp |
Director |
|
2007-04-24 |
4 |
A |
$23.98 |
$74,985 |
D/D |
3,127 |
15,465 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2006-04-25 |
4 |
A |
$28.14 |
$74,993 |
D/D |
2,665 |
7,151 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2013-08-01 |
4 |
S |
$76.02 |
$76,020 |
D/D |
(1,000) |
400 |
0 |
- |
|
BCR |
CR Bard Inc |
Director |
|
2015-04-28 |
4 |
OE |
$63.43 |
$76,116 |
D/D |
1,200 |
9,519 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2015-05-21 |
4 |
OE |
$51.77 |
$77,655 |
D/D |
1,500 |
1,500 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-01-15 |
4 |
A |
$0.85 |
$85,000 |
D/D |
100,000 |
130,000 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2017-06-21 |
4 |
D |
$131.93 |
$85,755 |
D/D |
(650) |
1,750 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2020-04-06 |
4 |
AS |
$58.00 |
$87,000 |
D/D |
(1,500) |
380,928 |
0 |
% |
|
CNC |
Centene Corp |
Director |
|
2020-10-01 |
4 |
AS |
$58.36 |
$87,540 |
I/I |
(1,500) |
160,896 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2023-06-02 |
4 |
OE |
$88.03 |
$88,030 |
D/D |
1,000 |
8,600 |
0 |
- |
|
284 Records found
|
|
Page 8 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|